CEO Jean Jacques Bienaime sold $2.3M of BioMarin Pharmaceutical Inc.

Sold$2,306,550

$109.84Price

21,000Shares

−4%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, Feb 10. Filed Tue, Feb 14, 8:00 PM ET, after the close. Not investment advice.